Discovery and Development of Doravirine: An Investigational Next Generation Non-Nucleside Reverse Transcriptase Inhibitor (NNRTI) for the Treatment of HIV
- 1 January 2016
- book chapter
- Published by American Chemical Society (ACS)
- p. 175-205
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- HIV Integrase Inhibitors2013
- The flow synthesis of heterocycles for natural product and medicinal chemistry applicationsMolecular Diversity, 2010
- Fifteen years of HIV Protease Inhibitors: raising the barrier to resistanceAntiviral Research, 2010
- Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptasesBioorganic & Medicinal Chemistry Letters, 2007
- Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptaseBioorganic & Medicinal Chemistry Letters, 2006
- Tetrazole thioacetanilides: Potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutantBioorganic & Medicinal Chemistry Letters, 2006
- Palladium‐Catalyzed Cyanation of Aryl Halides: Recent Developments and PerspectivesEuropean Journal of Inorganic Chemistry, 2003
- A Stoichiometric Aromatic C-H Borylation Catalyzed by Iridium( I )/2,2′‐Bipyridine Complexes at Room TemperatureAngewandte Chemie International Edition, 2002
- Estimation of the aqueous solubility I: Application to organic nonelectrolytesJournal of Pharmaceutical Sciences, 2001
- Approval of Zidovudine (AZT) for Acquired Immunodeficiency SyndromeJAMA, 1987